You are here

Главная страница › U.S. FDA lifts clinical hold on Novavax's combined COVID-flu shot › U.S. FDA lifts clinical hold on Novavax's combined COVID-flu shot

U.S. FDA lifts clinical hold on Novavax's combined COVID-flu shot

Primary tabs

U.S. FDA lifts clinical hold on Novavax's combined COVID-flu shot

Tue, 2024-11-12 09:34 — mike kraft
US FDA lifts clinical hold on Novavax's combo COVID-flu shot The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated to the combination shot, the company said. Reuters Reuters

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Seasonal Flu
Boosters
Disease Prevention
Government
Public Health
Research
Problem, Solution, SitRep, or ?: 
Situation Report
Groups this Group Post belongs to: 
- Группа с ограниченным доступом -
Workflow history
Revision ID Название поля Date Old state New state name By Comment Действия
No state No state
howdy folks
Page loaded in 0.473 seconds.